SCHEMBL324741

SCHEMBL324741

C=CCN1C=CC(C=C)=CC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038278 0.81
SCHEMBL9352170 0.80
Hydrochloric Acid SCHEMBL10825586 0.79
Iodide SCHEMBL31300220 0.79
Iodide SCHEMBL31300221 0.79
SCHEMBL31300219 0.78
SCHEMBL5953412 0.77
Bromide SCHEMBL31300222 0.77
SCHEMBL10837058 0.75 GRM2 (0.34)
SCHEMBL28395753 0.70 MEN1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112204400-B Quantum dot beads having multifunctional ligands, and target antigen detection method and biological diagnostic device using the same 杰宜斯科技有限公司 2024-05-28 CN claimed
CN-112204400-A Quantum dot beads having multifunctional ligand, and target antigen detection method and biological diagnostic device using the same 杰宜斯科技有限公司 2021-01-08 CN claimed
US-20200405746-A1 COMPOSITIONS AND METHODS TO TREAT DISEASE REGENTS OF THE UNIVERSITY OF MINNESOTA 2020-12-31 US claimed
US-9783548-B2 Production method for epoxy compound using solid catalyst JX NIPPON OIL & ENERGY CORPORATION (JP) 2017-10-10 US claimed
US-20160347763-A1 PRODUCTION METHOD FOR EPOXY COMPOUND USING SOLID CATALYST JX NIPPON OIL & ENERGY CORPORATION (JP) 2016-12-01 US claimed
CN-1934657-B Composite polyelectrolyte composition TREKION CO LTD 2012-04-25 CN claimed
CN-1934657-A Composite polymer electrolyte composition TREKION CO LTD (JP) 2007-03-21 CN claimed
CN-112204400-B Quantum dot beads having multifunctional ligands, and target antigen detection method and biological diagnostic device using the same 杰宜斯科技有限公司 2024-05-28 CN disclosed
US-20230231508-A1 WINDOWS WITH POWER GENERATION FROM TRANSPARENT SOLAR ENERGY HARVESTING DEVICES COMPRISING WAVELENGTH-SPECIFIC ABSORBERS ANDLUCA TECHNOLOGIES INC. 2023-07-20 US disclosed
US-11382929-B2 Compositions and methods to treat disease REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2022-07-12 US disclosed
CN-112204400-A Quantum dot beads having multifunctional ligand, and target antigen detection method and biological diagnostic device using the same 杰宜斯科技有限公司 2021-01-08 CN disclosed
US-20200405746-A1 COMPOSITIONS AND METHODS TO TREAT DISEASE REGENTS OF THE UNIVERSITY OF MINNESOTA 2020-12-31 US disclosed
US-9783548-B2 Production method for epoxy compound using solid catalyst JX NIPPON OIL & ENERGY CORPORATION (JP) 2017-10-10 US disclosed
EP-2082021-B1 PREMOISTENED CLEANING DISPOSABLE SUBSTRATE BASF SE (DE) 2011-08-03 EP disclosed
US-7947086-B2 Method for cleaning household fabric-based surface with premoistened wipe THE PROCTER & GAMBLE COMPANY (US) 2011-05-24 US disclosed
CN-101990527-A Improved carbonylation process EASTMAN CHEM CO 2011-03-23 CN disclosed
EP-2082021-A1 PREMOISTENED CLEANING DISPOSABLE SUBSTRATE Ciba Holding Inc. (CH) 2009-07-29 EP disclosed
US-20080171683-A1 Premoistened cleaning disposable substrate for leather and method of preserving a leather surface by contacting said surface with said substrate BASF SE (DE) 2008-07-17 US disclosed
WO-2008059013-A1 PREMOISTENED CLEANING DISPOSABLE SUBSTRATE CIBA HOLDING INC. (CH) 2008-05-22 WO disclosed
CN-1934657-A Composite polymer electrolyte composition TREKION CO LTD (JP) 2007-03-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382929-B2 Compositions and methods to treat disease SGMS1, SGMS2, LIPA ADRA1D 4493/4885ADRA1A 3768/4885ADRA1B 4218/4885
US-20200405746-A1 COMPOSITIONS AND METHODS TO TREAT DISEASE SGMS1, SGMS2, LIPA ADRA1D 4493/4885ADRA1A 3768/4885ADRA1B 4218/4885
US-20160347763-A1 PRODUCTION METHOD FOR EPOXY COMPOUND USING SOLID CATALYST EPX, PPOX, MPO ADRA1D 4876/4885ADRA1A 4848/4885ADRA1B 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.